Clinical Trials Directory

Trials / Conditions / Monoclonal Gammopathy of Undetermined Significance (MGUS)

Monoclonal Gammopathy of Undetermined Significance (MGUS)

8 registered clinical trials studyying Monoclonal Gammopathy of Undetermined Significance (MGUS) — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingCHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
NCT06644625
Wake Forest University Health Sciences—
Enrolling By InvitationA Study of Carbon 13-based Deep Labelling of Bone Marrow Cells
NCT07057583
Mayo Clinic—
RecruitingCharacteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy
NCT06690593
Zhujiang Hospital—
RecruitingA Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to M
NCT06140524
Regeneron PharmaceuticalsPhase 2
Active Not RecruitingIntegrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution
NCT07214324
Azienda USL Reggio Emilia - IRCCS—
RecruitingA Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH
NCT05283993
Peking University First Hospital—
CompletedThe Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Los
NCT03951220
Oxford University Hospitals NHS Trust—
RecruitingStudy of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Ou
NCT02269592
Dana-Farber Cancer Institute—